Mir-22 inhibits the proliferation, migration, and invasion of human CD133-positive glioblastoma stem cells
These results suggest that miR-22 acts as a tumor suppressor in GBM and CD133<sup>+</sup> GSCs. Therefore, miR-22 represents a potential therapeutic target for cancer stem cell-based glioblastoma treatment.
Authors
- Sevil Köse (ORCID: https://orcid.org/0000-0003-2188-9534)
- ÖMER ÖZKAN
- ÖZLENEN ÖZKAN
Institutions
- Akdeniz University (TR)
Publication Details
- Journal
- TURKISH JOURNAL OF BIOLOGY
- Published
- 2025-12-29
- DOI
- https://doi.org/10.55730/1300-0152.2781
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00